Search
News
Hopkins researchers chart a course for AI-aided diagnosis of degenerative eye conditions
An interdisciplinary team discovers that machine diagnostics using deep learning can match the performance of human ophthalmologists
News
Artificial Corneas: A Glimmer of Hope Through the Cloud
Sightline Special Edition Annual Report 2014
Course
Retinopathy of Prematurity (ROP): Treatment and Results
Dr. Harper reviews the options for retinopathy of prematurity treatment; recent advancements in diagnostic evaluation and treatment considerations and results.
Video
Plaque Placement for a Choroidal Melanoma
MUSC Health ophthalmologist George N. Magrath, M.D., narrates video footage showing the placement of a radioactive plaque to treat choroidal melanoma.
News
Precision Medicine for Patients with Neurofibromatosis
Neurofibromatosis Precision Medicine Center of Excellence works to mine untapped volumes of clinical data and use it for research that can benefit patients with neurofibromatosis.
News
Building a Better Cornea
Partnering with Industry to Improve Patient Outcomes
News
Dried goji berries may provide protection against age-related macular degeneration
Regularly eating a small serving of dried goji berries may help prevent or delay the development of age-related macular degeneration, in healthy middle-aged people, according to a randomized trial conducted at UC Davis.
News
New Hypoparathyroidism Guidelines and Emerging PTH Replacement Therapies for Improved Patient Outcomes
New guidelines from the Second International Workshop on the Evaluation and Management of Hypoparathyroidism provide clinicians with the latest evidence-based recommendations for the prevention, diagnosis and management of this rare disease.
News
Deciphering the Complexities of a Rare Disease
Birdshot, as it is familiarly known, is an autoimmune disease that occurs when the body’s immune system mistakenly attacks healthy tissue.
News
Novel Stem Cell Therapy Safely Repairs Irreversible Corneal Damage in Clinical Trial
An expanded phase clinical trial that tested a groundbreaking, experimental stem cell treatment for blinding cornea injuries found the treatment was feasible and safe in 14 patients who were treated and followed for 18 months, and there was a high proportion of complete or partial success.
News
Miami Neuroscience Symposium Advances Brain and Spine Care
By developing new technologies and procedures that are advancing care for a host of neurological conditions, physicians at Baptist Health Miami Neuroscience Institute are enabling more patients to take advantage of treatments for debilitating and life-threatening problems.
News
Rapid Response to Immune-Related Adverse Events Improves Patient Care
Published results of a Johns Hopkins pilot study showed 73.5% of physicians in the study said recommendations from an immune-related toxicity (IR-tox) team changed their diagnosis or management of immune-related adverse events.